NAFARELIN | NAFARELIN | ATC H01CA02
HORMONES TREATMENT OF CENTRAL PRECOCIOUS PUBERTY (CPP) GONADOTROPIN-RELEASING HORMONE AGONIST | NASAL | Cmax 1.36 NANOMOLAR Tmax 0.4 HOUR F 2.8 PERCENT PPB 80 PERCENT HT 3 HOUR | GONADOTROPIN-RELEASING HORMONE RECEPTOR GONADOTROPIN-RELEASING HORMONE II RECEPTOR | GONADOTROPIN-RELEASING HORMONE RECEPTOR AGONIST CHEMBL1855 GONADOTROPIN-RELEASING HORMONE RECEPTOR P30968 GONADOTROPIN-RELEASING HORMONE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 PEPTIDE SHORT PEPTIDE GNRH RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |